• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 76 of 100
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
HealthMerck CEO: We’re on the Hunt for Deals in 2016
By Sy MukherjeeMay 6, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
HealthValeant Says it Has a New Way to Ensure it Doesn’t Price Gouge So Much
By ReutersMay 6, 2016
Sanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger
HealthSanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger
By ReutersMay 6, 2016
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
HealthNow It’s Pfizer That Wants to Buy Cancer Drug Maker Medivation
By ReutersMay 4, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
FinanceThese Biopharma Companies Are the World’s Top Shareholder Value Creators
By Sy MukherjeeMay 3, 2016
172646513
HealthU.S. Approves First Drug for Psychosis Linked to Parkinson’s
By ReutersApril 30, 2016
493534821
HealthBig Pharma Under Pressure to Pay For Drug Take-Back Programs
By Sy MukherjeeApril 30, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
FinanceAbbVie Buying Cancer Drug Startup Stemcentrx for $10.2 Billion
By Dan PrimackApril 28, 2016
Sanofi Just Made a Hostile $9.3 Billion Bid for This San Francisco Drugmaker
HealthSanofi Just Made a Hostile $9.3 Billion Bid for This San Francisco Drugmaker
By ReutersApril 28, 2016
Squawk Box - Season 20
FinanceBill Ackman: Valeant’s Drug Price Hikes Hurt America
By Sy MukherjeeApril 27, 2016
547016547
HealthWhy Biogen Is Poaching This Pfizer Exec to Head Up Its R&D Shop
By Sy MukherjeeApril 27, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
LeadershipValeant CEO to Tell Senate Jacking Up Heart Drug Prices Was a ‘Mistake’
By ReutersApril 27, 2016
Here’s How Drug Prices Actually Work
FinanceHere’s How Drug Prices Actually Work
By Lauren Silva LaughlinApril 26, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
HealthSenate Calls for Former Valeant CFO to Testify at Hearing
By Laura LorenzettiApril 26, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
HealthThis Rare Children’s Disease Drug Is Pitting Patients Against the FDA
By Sy MukherjeeApril 26, 2016
1...
  • 74
  • 75
  • 76
  • 77
  • 78
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.